Patient preference information

The latter, termed patient preference information, “captures the value that patients place on aspects of the medical device in a way that accounts for differing patient perspectives on benefits and risks that come with using that device or treating the condition” .Patient preference information-voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling: guidance for industry, food and drug administration staff, and other stakeholders.Health preference research (HPR) is being increasingly conducted to better understand patient preferences for medical decisions.Therefore, it is essential to identify patient perspectives regarding the value of patient preference information (PPI).Advancing the Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation: A Summary Report of the Patient Preference Workshop Patient . In this paper, . A specific method for measuring stated preferences that is increasingly applied in both clinical and health policy contexts is the DCE .Patient preference information can inform the design of a medical device, impact how a clinical study is designed and be used to understand the impact of the clinical study .Schlagwörter:Patient Preference InformationPatient PreferencesMedical Preferences

PREFER Focuses on Patient Preferences

With support already being generated by all these stakeholders, this study provides an overview of 15 decision-points with the potential to include PP information. Food and Drug Administration Staff, and . 18 Patient preferences, collected through means such as interviews, focus groups or .Data extraction and synthesis.• FDA are writing 4 guidance documents on Patient-Focused Drug Development • CDRH already have a guidance in place on the use of patient preference information in .Schlagwörter:Patient PreferencesMedical PreferencesSchlagwörter:Patient PreferencesMedical ResearchPatient preference studies (PPS) assess what matters most to patients, how much, and what trade-offs patients are willing to make. Survey data were augmented with data from electronic . Patients are the most familiar with their own health conditions. Until now, few studies have considered patients’ preferred roles in decision making.Schlagwörter:Publish Year:2019This research sought to assess whether and how patient preference (PP) data are currently used within health technology assessment (HTA) bodies and affiliated organizations involved in technology/drug appraisals and assessments.Patient preference information can help identify outcomes that are most important and assess the relative importance of treatment benefits and risks to patients.

Objectives: Inclusion of patient preference (PP) data in decision making has been largely discussed in recent years.1) Why Patient Preference Information (PPI)? 2) What is PPI, What Does PPI Measure and Methods for PPI? 3) Analysis and Interpretation of Results from PreferencesSchlagwörter:Patient Preference InformationPatient Preferences

(PDF) Patient Preferences for Information on Post-Acute Care Services

Schlagwörter:Patient PreferencesPublish Year:2020

Brief Overview of Patient Preference Information (PPI)

This review provides an overview of the psychological factors and related instruments in the context of patients‘ preferences and decisions in healthcare settings. They are best positioned to provide a real-world understanding of their experiences and . An exploratory survey was developed by the PP Project Subcommittee of the HTA International Patient .” 1 In medical settings, patients are often asked to decide from . Studies on the assessment of patient preferences can be very easily biased if the following aspects are not considered very carefully:1%) or multiple (42. Patient preferences (PPs) are defined by the US Food and Drug Administration as the “relative desirability or acceptability to patients of specified alternatives or choices among outcomes or other attributes that differ among alternative health interventions.These studies, usually DCEs, can be used as part of a drug’s clinical development programme; to inform the selection of appropriate endpoints .Patient preference (PP) information is currently not routinely considered one of the requirements for decision-making. Objectives: The aim of this study was to explore how patients with rheumatoid arthritis (RA) value the use of PPI in .Schlagwörter:Patient PreferencesPublish Year:2020Clinical Guidelines

Why, when and how to assess and use patient preferences in

Patient preferences, defined broadly as ‘the desire for specific satisfiers of basic needs’ and referring to perspectives, values or priorities related to health and health care, are associated with patient satisfaction with health-care experiences. 56 A conceptual review of . For example, patients may prefer medication or psychotherapy, have preferences for one type of medication over another based on side effects, or have preferences for one type of psychotherapy over . Therefore, it is essential to identify patient perspectives regarding the value of patient preference information (PPI). However, there is little guidance on which patient preference assessment methods, including preference exploration (qualitative) and elicitation (quantitative) methods, are most suitable for decision-making . 54 , 55 A systematic review that included 20 studies published from 1999 to 2017 found that few developed or assessed the properties of questionnaires designed to measure patient preferences.• Patient preference information (PPI) is useful for understanding what matters most to patients and the trade-offs they make when making a treatment decision. A recently published report offers insights on the opportunities to leverage PPI, such as how to maximize stakeholder engagement, identifying novel . We reported approaches for and determinants and impacts of identifying patient preferences using summary statistics and text, and .Schlagwörter:Patient Preference InformationPublish Year:2019

Patient Preference Information

Patient preference information can help to identify the most important outcomes and assess the relative importance of benefits and risks to patients .To incorporate the patient voice, patient preferences need to be explicitly explored or elicited through revealed- or stated-preference methods. However, patients vary in their desire to play an active role in medical decisions. It aims to 1) identify criteria most important for appraising .Background: There is increasing interest in involving patient preferences for benefits and risks in regulatory decision making.Patient preferences refer to the specific activity, treatment and provider conditions that patients desire for their health care experience 1, 2. Patient preferences information studies conducted to fill these gaps in patient preferences data .Incorporating patient preference (PP) information into decision-making has become increasingly important to many stakeholders. Patient tolerance for risk may be influenced by factors such as severity and/or .Patients and methods: Utilizing a cohort of idiopathic pulmonary fibrosis (IPF) patients across a CDRN, a discrete choice experiment was administered via electronic and paper methods to collect patient preference information about benefits and risks of two therapeutic options.

Patient Preference Information (PPI) in Healthcare: What is it, and How ...

Symposium Title: Preference Evidence for Regulatory Decisions

Background: While patient-level determinants of total thyroidectomy use have been well described, surgeon-level drivers of more extensive surgery are present .Prior research explored what patients or the public know about and expect from clinical practice guidelines.Pharmaceutical companies are increasingly using patient preference studies to ensure the products they develop align with patients’ needs and will provide the benefits the patients are seeking [].

Avalere and FasterCures Release Patient-Perspective Value Framework to ...

Patient Preference Information–Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decision Summaries and Device Labeling: Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders.Featuring experts from the FDA, ISPOR, medical device manufacturers, health economics, healthcare, and patient groups, the 4 sessions in the Summit clarified what patient .Use of Patient Preference Information in Beneﬁt–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and .Patient preference information (PPI) refers to assessments of the relative desirability or acceptability to patients of specified alternatives or choices among outcomes or other attributes that differ among alternative health interventions.Studies employed single (57. The methods for generating PPI may be qualitative, quantitative, or mixed methods.Patient preferences cannot be determined in general, but have to be recorded separately for each disease.Patient preference information, or patient preferences, reflects what treatment attributes matter to patients, how much these matter to patients and how .1%) incorporated preferences in one aspect of guideline .Schlagwörter:Patient PreferencesPublish Year:202010.Schlagwörter:Patient Preference InformationPatient Preferences

Integrate Evidence With Clinical Expertise and Patient Preferences and ...

Schlagwörter:Patient PreferencesPublish Year:2019Medical PreferencesPatients are the most important actors in clinical research.The US Food and Drug Administration (FDA) has increasingly called for the inclusion of patient preference information (PPI) to inform its regulatory decision-making for medical devices. The results of a single patient . Patient tolerance for risk may be influenced by factors such as severity and/or chronicity of .Schlagwörter:Patient Preference InformationPublish Year:2019

Frontiers

Schlagwörter:Patient Preference InformationMedical DevicesClinical TrialsSchlagwörter:Patient Preference InformationPublish Year:2019 However, there is a lack of clear guidance or consensus on the search for preference studies.Patient preferences are useful for informing preference-sensitive decisions during multiple phases of the medical product life cycle.

How Can Patient Preference Information Be Used in Payer Coverage ...

The US Food and Drug Administration (FDA) .This study proposes a means of choosing between methods eliciting and exploring patient preferences. This requires well-designed studies in which patients are interviewed without being influenced.This guidance document provides guidance on patient preference information (PPI) that may be used by FDA staff in decision making related to PMAs, HDE applications, and de .Several initiatives have sought to help guide the collection, analysis, and interpretation of such information [4,5,6].Patient preference information can be collected using a variety of approaches, both qualitative and quantitative, tailored to fit the research needs of a study.Patient preference information can clarify what benefits and risks are most important to patients. Health economic .The white paper How Can Patient Preference Information be Used in Payer Coverage Decisions and Health Technology Assessment? aims to encourage the use of patient preference information by payers and health technology assessment organizations.1007/s43441-022-00450-9 Corpus ID: 251882243; Leveraging Patient Preference Information in Medical Device Clinical Trial Design @article{RinconGonzalez2022LeveragingPP, title={Leveraging Patient Preference Information in Medical Device Clinical Trial Design}, author={Liliana Rincon-Gonzalez . Objectives: The aim of this study was to explore how .PREFER is a five-year public-private research project working to develop evidenced-based recommendations on how and when to assess and use patient preference in . Healthcare decision makers-regulatory and health technology assessment (HTA)-are more and more conscious of the need for a patient-centered approach to decide on optimal allocation of scarce money, time, and .9%) methods for identifying preferences. This roadmap, combined with continued discussion between .Patient preference information (PPI) is a way to incorporate the patient voice in the evaluation of medical devices.Schlagwörter:Patient Preference InformationFda Patient Preference Guidance

Patient Preference-Sensitive Areas: Using Patient Preference ...

The US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) has been working to encourage the voluntary inclusion of PPI throughout the medical device lifecycle for nearly a decade. In this resource, MDIC clarifies the standards and role of generating this .1007/s40271-019-00396-5. The novel mixed-methods approach employed in this study efficiently captured patient preference data that were informative for exploratory research, internal decision making, . Therefore, patient preference information (PPI) could support the decision-making process, being indisputable for research value, quality, and integrity. Leveraging Patient Preference .

Eliciting Exploratory Patient Preference Data: A Case Study

In this blueprint, an openly .Schlagwörter:Patient PreferencesFront Pharmacol.The medical device innovation consortium (MDIC) undertook a series of projects, including multiple case studies and expert consultations, to identify approaches . By permitting patients to state their preferences, it .Interest in regulatory use of patient-preference information has been growing in recent years [1,2,3].Use of robust, quantitative tools to measure patient perspectives within product development and regulatory review processes offers the opportunity for medical device researchers, regulators, and other stakeholders to evaluate what matters most to patients and support the development of products tha .Schlagwörter:Patient Preference InformationTreatment PreferencesThese initiatives have taken place in the context of a broader evolution in regulatory science and benefit–risk evaluations [3, . In this opinion paper, we advocate for HPR . 2023; 14: 1192770. 2019 Dec;12(6):553-557.Patient preference information studies provide an opportunity to develop a representative or generalizable picture of patient experience and to capture preference .